Literature DB >> 11304039

Acute focal demyelinating disease simulating brain tumors: histopathologic guidelines for an accurate diagnosis.

Y Sugita1, M Terasaki, M Shigemori, K Sakata, M Morimatsu.   

Abstract

The object of the present study was to determine the histopathological guidelines for accurate diagnosis of cases of acute focal demyelinating disease that simulates brain tumors. The surgical pathology of three such cases is assessed. Histopathological keys to the diagnosis of such cases are as follows. First, a pattern of sheets of atypical gemistocytic astrocytes in the white matter that show well-formed processes and that are adequately distanced from each other argues against a diagnosis of neoplasm. Second, uniform distribution of foamy macrophages aligned along axons, with occasional focal collections surrounding blood vessels and in the absence of any associated coagulative necrosis argues against the presence of a tumor. Third, perivascular chronic inflammatory infiltration, especially a mixture of lymphocytes and macrophages, favors the diagnosis of demyelination plaque. In such cases the lymphocytes will be predominantly T cells. Fourth, pleomorphic astrocytic proliferation with a lack of vascular endothelial proliferation should raise the suspicion that the lesion may not be a brain tumor. These diagnostic keys should be followed when diagnosing cases that are suspected to be demyelination processes rather than brain tumors. The presence of demyelination plaque should then be confirmed by imaging modalities such as staining with myelin-and axon-specific stains.

Entities:  

Mesh:

Year:  2001        PMID: 11304039     DOI: 10.1046/j.1440-1789.2001.00365.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  10 in total

1.  Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging.

Authors:  C H Toh; K-C Wei; S-H Ng; Y-L Wan; M Castillo; C-P Lin
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

Review 2.  Is the brain biopsy obligatory or not for the diagnosis of Schilder's disease? Review of the literature.

Authors:  Yuksel Yilmaz; Canan Kocaman; Hakan Karabagli; Memet Ozek
Journal:  Childs Nerv Syst       Date:  2007-08-25       Impact factor: 1.475

Review 3.  MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

Authors:  A Seewann; C Enzinger; M Filippi; F Barkhof; A Rovira; A Gass; D Miller; X Montalban; A Thompson; T Yousry; M Tintore; N de Stefano; J Palace; M Rovaris; C Polman; F Fazekas
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

Review 4.  Perfusion CT imaging of brain tumors: an overview.

Authors:  R Jain
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

5.  5-aminolevulinic acid fluorescence in tumefactive demyelinating lesion.

Authors:  Naohisa Miyagi; Shinji Nakashima; Tetsuya Negoto; Shinichirou Mori; Satoru Komaki; Motohiro Morioka; Yasuo Sugita
Journal:  Neurosurg Rev       Date:  2018-03-01       Impact factor: 3.042

6.  Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

Authors:  Rajan Jain; Shehanaz Ellika; Norman L Lehman; Lisa Scarpace; Lonni R Schultz; Jack P Rock; Mark Rosenblum; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-10-15       Impact factor: 4.130

7.  Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report.

Authors:  Maria Gavra; Efstathios Boviatsis; Lampis C Stavrinou; Damianos Sakas
Journal:  J Med Case Rep       Date:  2011-06-07

8.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

9.  Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System.

Authors: 
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

10.  Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect.

Authors:  Frederico Carvalho de Medeiros; Lucas Alverne Freitas de Albuquerque; Jose Eymard Homem Pittella; Renata Brant de Souza; Antonio Pereira Gomes Neto; Paulo Pereira Christo
Journal:  Case Rep Neurol Med       Date:  2014-04-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.